Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.58% | 63.58% | 63.10% | 51.82% | 40.26% |
| Total Depreciation and Amortization | -36.51% | -2.79% | -0.55% | 2.26% | 17.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.44% | -66.01% | -74.19% | -77.38% | -67.35% |
| Change in Net Operating Assets | 161.06% | 211.43% | 118.23% | 129.77% | 71.78% |
| Cash from Operations | 79.75% | 75.22% | 63.97% | 44.94% | 29.04% |
| Capital Expenditure | 100.00% | 100.00% | 94.33% | 93.91% | 64.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -184.32% | -126.21% | -78.28% | 187.12% | -86.92% |
| Cash from Investing | -188.95% | -126.65% | -77.93% | 205.65% | -83.03% |
| Total Debt Issued | -100.00% | -100.00% | -77.50% | -77.50% | -- |
| Total Debt Repaid | 90.50% | 90.74% | 35.69% | -630.16% | -165,938.64% |
| Issuance of Common Stock | -26.41% | -35.86% | -27.04% | -23.14% | 5.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.81% | 79.10% | 19.12% | 32.68% | -1,886.30% |
| Cash from Financing | -48.29% | -61.25% | -75.66% | -112.02% | 11.94% |
| Foreign Exchange rate Adjustments | -148.89% | -218.18% | 233.33% | -110.77% | -56.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.22% | -377.80% | -207.54% | -168.25% | -478.92% |